Description
Brazil
Canada - English
Canada - Français
Deutschland
France
Ελλάδα
Ireland
Latin America
Spain
United Kingdom
日本
Other Countries
New data clarifies the benefit of chemotherapy in early-stage, node-positive breast cancer patients with Recurrence Score® results of 0 to 25.
For a refined risk estimateof local recurrence
New follow-up data for the Oncotype DX GPS assay
Nuclear-specific vs. nuclear-agnostic AR-V7 testing
Help Stage II colon cancer patients understand the power of genomics
Your Oncotype DX score can help you decide.
Oncotype DX has helped thousands of women find out.
When Dan's Colon Recurrence Score came back low, he decided against chemotherapy.
oncotype-dx-breast-dcis-score
oncotype-dx-breast-recurrence-score
RESET FILTERS
Recurrence Score® result: 13
Recurrence Score® result: 22
Recurrence Score® result: 35
Recurrence Score® result: 11
Recurrence Score® result: 25
Recurrence Score® result: 24
Recurrence Score® result: 33
Recurrence Score® result: 32
Recurrence Score® result: 27
Recurrence Score® result: 18
Recurrence Score® result: 37
Recurrence Score® result: 15
Recurrence Score® result: 30
Recurrence Score® result: 31
Recurrence Score® result: 19
Recurrence Score® result: 26
Recurrence Score® result: 41
Recurrence Score® result: 12
Recurrence Score® result: 39
Recurrence Score® result: 43
Recurrence Score® result: 16
Recurrence Score® result: 38
Recurrence Score® result: 42
Recurrence Score® result: 0